In this study, patients receiving chemotherapy underwent a GC genotype mutation at the G553C locus of the EZH2 gene in the primary lung cancer lesion after progression, while patients who did not receive treatment only showed a C genotype in brain metastasis resection samples one month later. Here, EZH2 is linked to lung cancer.